Comments on Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Comments on Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam Business news, opinion, reviews, interviews 2026-05-28T05:15:00Z https://thegbm.com/basilea-receives-further-usd-13-million-from-barda-to-continue-development-of-novel-antibiotic-ceftibuten-ledaborbactam/feed/atom/ WordPress